Skip to main navigation Skip to search Skip to main content

Triple therapy for T1DM with insulin, semaglutide and dapagliflozin

Project: Research

Project Details

StatusActive
Effective start/end date01/1/1912/31/26

Funding

  • Breakthrough T1D: $2,600,706.69